Oscar Health, Inc. (NYSE:OSCR) Receives $26.22 Consensus PT from Brokerages

Oscar Health, Inc. (NYSE:OSCR) has been assigned a consensus rating of “Hold” from the twelve brokerages that are covering the firm, MarketBeat.com reports. Eight research analysts have rated the stock with a hold rating, three have assigned a buy rating and one has given a strong buy rating to the company. The average 12-month price objective among brokerages that have covered the stock in the last year is $26.2222.

Several equities analysts have recently commented on OSCR shares. Weiss Ratings raised shares of Oscar Health from a “sell (d+)” rating to a “hold (c+)” rating in a research note on Tuesday, August 11th. The Goldman Sachs Group restated a “neutral” rating and set a $30.00 price target on shares of Oscar Health in a report on Tuesday, August 11th. Robert W. Baird set a $27.00 price target on Oscar Health in a research report on Friday, August 7th. Wall Street Zen upgraded Oscar Health from a “buy” rating to a “strong-buy” rating in a report on Sunday, June 14th. Finally, Barclays lifted their price objective on Oscar Health from $35.00 to $39.00 and gave the stock an “overweight” rating in a research report on Thursday, August 6th.

Oscar Health News Summary

Here are the key news stories impacting Oscar Health this week:

• Neutral Sentiment: Director Mario Schlosser sold 31,422 shares for approximately $988,000 and retained 449,444 shares. Mario Schlosser SEC filing
• Neutral Sentiment: CFO Richard Blackley sold 28,869 shares valued at roughly $908,000, while continuing to own more than 1.04 million shares. Richard Blackley SEC filing
• Neutral Sentiment: Other insiders Adam Mcananey, Janet Liang and Chief Accounting Officer Victoria Baltrus sold approximately $642,000 combined. Each sale was also tied to tax obligations and represented only a modest reduction in their respective holdings. Adam Mcananey SEC filing Janet Liang SEC filing Victoria Baltrus SEC filing

Oscar Health Trading Up 2.0%

NYSE:OSCR opened at $32.90 on Friday. The company has a fifty day moving average of $30.58 and a 200 day moving average of $23.01. Oscar Health has a 52 week low of $10.69 and a 52 week high of $33.55. The company has a quick ratio of 1.09, a current ratio of 1.09 and a debt-to-equity ratio of 0.21. The firm has a market capitalization of $10.15 billion, a P/E ratio of 23.50, a P/E/G ratio of 0.66 and a beta of 2.37.

Oscar Health (NYSE:OSCR) last announced its quarterly earnings results on Thursday, August 6th. The company reported $1.10 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.40 by $0.70. The business had revenue of $4.88 billion for the quarter, compared to analyst estimates of $4.73 billion. Oscar Health had a net margin of 3.60% and a return on equity of 38.45%. The company’s revenue was up 70.4% on a year-over-year basis. During the same quarter last year, the firm earned ($0.89) EPS. On average, research analysts predict that Oscar Health will post 1.54 earnings per share for the current year.

Insiders Place Their Bets

In other news, CAO Victoria Baltrus sold 958 shares of the firm’s stock in a transaction dated Thursday, September 3rd. The shares were sold at an average price of $31.45, for a total value of $30,129.10. Following the completion of the sale, the chief accounting officer directly owned 213,631 shares of the company’s stock, valued at approximately $6,718,694.95. This trade represents a 0.45% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Richard Blackley sold 28,869 shares of Oscar Health stock in a transaction dated Thursday, September 3rd. The shares were sold at an average price of $31.45, for a total transaction of $907,930.05. Following the sale, the chief financial officer directly owned 1,046,108 shares in the company, valued at $32,900,096.60. The trade was a 2.69% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 4,322,257 shares of company stock valued at $126,818,346 over the last quarter. 22.64% of the stock is owned by company insiders.

Hedge Funds Weigh In On Oscar Health

A number of institutional investors have recently bought and sold shares of OSCR. Vanguard Group Inc. grew its holdings in shares of Oscar Health by 2.7% during the 4th quarter. Vanguard Group Inc. now owns 20,701,250 shares of the company’s stock worth $297,477,000 after acquiring an additional 540,851 shares during the period. Geode Capital Management LLC lifted its stake in shares of Oscar Health by 2.5% in the 4th quarter. Geode Capital Management LLC now owns 4,798,313 shares of the company’s stock valued at $68,964,000 after purchasing an additional 116,430 shares during the period. BIT Capital GmbH lifted its stake in shares of Oscar Health by 545.0% in the 4th quarter. BIT Capital GmbH now owns 6,186,267 shares of the company’s stock valued at $88,897,000 after purchasing an additional 5,227,152 shares during the period. Simplify Asset Management Inc. bought a new stake in shares of Oscar Health during the fourth quarter valued at approximately $2,948,000. Finally, Fortis Group Advisors LLC boosted its position in shares of Oscar Health by 82.9% during the fourth quarter. Fortis Group Advisors LLC now owns 189,857 shares of the company’s stock valued at $2,724,000 after purchasing an additional 86,035 shares in the last quarter. 75.70% of the stock is owned by institutional investors.

About Oscar Health

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.